scispace - formally typeset
J

Jie Lu

Researcher at Capital Medical University

Publications -  19
Citations -  2055

Jie Lu is an academic researcher from Capital Medical University. The author has contributed to research in topics: Brain ischemia & Resting state fMRI. The author has an hindex of 13, co-authored 18 publications receiving 1703 citations. Previous affiliations of Jie Lu include Harvard University.

Papers
More filters
Journal ArticleDOI

Individual Variability in Functional Connectivity Architecture of the Human Brain

TL;DR: Using repeated-measurement resting-state functional MRI to explore intersubject variability in connectivity revealed that regions predicting individual differences in cognitive domains are predominantly located in regions of high connectivity variability.
Journal ArticleDOI

An open science resource for establishing reliability and reproducibility in functional connectomics

Xi-Nian Zuo, +85 more
- 09 Dec 2014 - 
TL;DR: The Consortium for Reliability and Reproducibility (CoRR) has aggregated 1,629 typical individuals’ resting state fMRI data from 18 international sites, and is openly sharing them via the International Data-sharing Neuroimaging Initiative (INDI).
Journal ArticleDOI

Focal Pontine Lesions Provide Evidence That Intrinsic Functional Connectivity Reflects Polysynaptic Anatomical Pathways

TL;DR: Results provide direct evidence that functional connectivity depends on intact connections within a specific polysynaptic pathway within the cerebrocerebellar circuits.
Journal ArticleDOI

Relaxation-compensated fast multislice amide proton transfer (APT) imaging of acute ischemic stroke.

TL;DR: This study has established a fast volumetric pH‐weighted APT imaging technique, allowing further investigation to fully evaluate its diagnostic power.
Journal ArticleDOI

Annexin A2 combined with low-dose tPA improves thrombolytic therapy in a rat model of focal embolic stroke

TL;DR: The present findings provide a promising new approach for enhancing tPA-based thrombolytic stroke therapy by combining annexin A2 with tPA so that lower doses of tPA can be applied in ischemic stroke to avoid neurotoxic and hemorrhagic complications.